| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 6 Aug 2025 | 30 Jul 2025 |
| Polychem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2025 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30 2025 | ||
| Board Meeting | 29 Jul 2025 | 29 Jul 2025 |
| We wish to state that the board of directors (Board) of Polychem Limited (Company) at their meeting held today i.e. 29th July, 2025, has inter alia approved the items as mentioned in the Letter | ||
| Board Meeting | 14 May 2025 | 7 May 2025 |
| Polychem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 inter alia to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended March 31 2025 and declaration of dividend if any. 1. Approved Results for the quarter and year ended 31st March, 2025. 2. Approved Dividend 3. Apt of Internal Auditor 4. Apt of Secretarial Auditor Re-appointment of Internal Auditor and Appointment of Secretarial Auditor. (As Per BSE Announcement dated on 14.05.2025) | ||
| Board Meeting | 11 Feb 2025 | 3 Feb 2025 |
| POLYCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended December 31 2024 The Board of Directors in their Meeting held on 11th February, 2025 has inter alia, approved the Standalone and Consolidated Unaudited Financial Results for the Quarter and Nine Months ended December 31, 2024 (As per BSE Announcement Dated on 11/02/2025) | ||
| Board Meeting | 13 Nov 2024 | 5 Nov 2024 |
| POLYCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended September 30 2024. The Board of Directors in their Meeting held on 13th November, 2024 has approved the Standalone and Consolidated Unaudited Financial Results for the Quarter and half year ended September 30, 2024. Accordingly, we are sending herewith the Standalone and Consolidated Unaudited Financial Results along with the respective Independent Auditors Review Reports for the Quarter and half year ended September 30, 2024 received from the Statutory Auditors, M/s. Nayan Parikh & Co. (As Per BSE Announcement Dated on: 13/11/2024) | ||
| Board Meeting | 8 Aug 2024 | 1 Aug 2024 |
| POLYCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended June 30 2024. The Board of Directors of the Company in their Meeting held today i.e. 8th August, 2024 have inter-alia approved the following: a) The Standalone and Consolidated Unaudited Financial Results along with the respective Independent Auditors Review Reports for the Quarter ended June 30, 2024 received from the Statutory Auditors, M/s. Nayan Parikh & Co. b) Revised Authorized KMP to determine Material Events under regulations 30(5) of SEBI (LODR) Regulations, 2015 (As per BSE Announcement Dated on 08/08/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.